Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gadolinium-based contrast agent BAY1747846

A gadolinium (Gd)-based contrast agent (GBCA) that can potentially be used for contrast-enhanced MRI (CE-MRI). Upon intravenous administration of GBCA BAY1747846, and upon placement in a magnetic field, this agent produces a large magnetic moment and creates a large local magnetic field, which can enhance the relaxation rate of nearby protons. This change in proton relaxation dynamics increases the MRI signal intensity of tissues in which this agent has accumulated due to abnormal vascularity and altered perfusion. This allows for enhanced contrast and visualization of those tissues compared to unenhanced MRI.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:GBCA BAY1747846
Gd-based contrast agent BAY1747846
Code name:BAY 1747846
BAY1747846
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search